Skip to main content
Skip to main content
NVZMF logo

Novozymes A/S (NVZMF) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$65.63 +$0.39 (+0.60%) |CouncilBullish Lean · 61 · B+
MCap: $30.6B| P/E Ratio: 41.02| Vol: 100| 52-wk range: $52.10 – $72.98

P/E 41.02 means the share price is 41.02 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $30.6B is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Novozymes A/S (NVZMF) trades at $65.63. Novozymes A/S is a leading producer of industrial enzymes and microorganisms, catering to various sectors including food and beverage, agriculture, and household care. Market cap: $30.6B, Sector: Basic materials.

Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026
Novozymes A/S is a leading producer of industrial enzymes and microorganisms, catering to various sectors including food and beverage, agriculture, and household care. With a strong market presence in Europe, North America, and Asia, the company is positioned for continued growth in the specialty chemicals industry.

Analyst Coverage for NVZMF: NVZMF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NVZMF against Basic Materials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the NVZMF film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

Council Score · Weighted Average of 3 Disciplines
Bullish Lean 61/100 · B+

NVZMF: 1/2 scored disciplines lean bullish. Dominant signal: Izzy Englander bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Novozymes A/S (NVZMF) Materials & Commodity Exposure

CEOEster Baiget
Employees11,641
HeadquartersBagsvaerd, DK
IPO Year2010

Novozymes A/S stands out in the specialty chemicals sector by producing a diverse range of industrial enzymes and microorganisms, driving innovation in food, agriculture, and household care solutions across global markets.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for NVZMF?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

The company's profit margin of 8.4% and gross margin of 53.6% indicate strong operational efficiency. Key growth catalysts include the increasing demand for sustainable solutions in the food and beverage sector, as well as the expansion of its agricultural products, which are projected to grow significantly in the coming years. The global enzymes market is expected to reach $10 billion by 2026, providing Novozymes with ample opportunity to capture market share. However, potential risks include fluctuations in raw material prices and competition from other specialty chemical companies. Overall, Novozymes' innovative product offerings and strong market position make it a noteworthy player in the specialty chemicals industry.

Based on FMP financials and quantitative analysis

NVZMF Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Market Cap of $30.6B reflects strong investor confidence and growth potential.

  • P/E ratio of 41.02 indicates favorable valuation compared to industry norms.
  • Profit Margin of 8.4% showcases efficient cost management and profitability.
  • Gross Margin of 53.6% exceeds industry average, highlighting strong pricing power.
  • Dividend Yield of 1.82% offers a steady income stream for investors.

Who Are NVZMF's Competitors?

NVZMF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AIQUF L'Air Liquide S.A. $194.91 -0.36% $124B
AKZOF Akzo Nobel N.V. $67.41 -2.74% $11.5B 449-signal
APD Air Products and Chemicals, Inc $292.62 -0.35% $65.2B 445-pillar
GVDNY Givaudan S.A. $77.63 -1.30% $35.8B 539-signal
SXYAY Sika AG $22.70 -1.77% $36.4B 479-signal
PPG PPG Industries, Inc. $105.86 +0.77% $23.5B 715-pillar
IFF International Flavors & Fragrances Inc. $83.61 -0.52% $21.4B 545-pillar
LYB LyondellBasell Industries N.V. $64.33 -0.28% $20.8B 505-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are NVZMF's Key Strengths?

Leading position in the industrial enzymes market.

  • Strong commitment to sustainability and innovation.
  • Diverse product offerings across multiple sectors.
  • Robust financial performance with healthy margins.

What Are NVZMF's Weaknesses?

Dependence on raw material prices which can be volatile.

  • Limited market presence in certain emerging regions.
  • Potential regulatory challenges in different markets.
  • High competition from established and emerging players.

What Could Drive NVZMF Stock Higher?

NVZMF catalyst: Expansion of product offerings in the agricultural sector to meet rising demand for sustainable farming solutions.

  • Continuous investment in research and development to drive innovation and maintain competitive advantage.
  • Strategic partnerships with key players in the food and beverage industry to enhance market penetration.
  • Efforts to increase operational efficiency and reduce costs, improving overall profitability.
  • Launch of new enzyme products tailored for emerging markets, targeting growth opportunities.

What Are the Key Risks for NVZMF?

Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.

  • Rich valuation — a P/E of 41.02 runs well above the Basic Materials sector’s ~21.40x, leaving little room for a miss.
  • Fluctuations in raw material prices could impact profit margins and overall financial performance.
  • Intense competition from other specialty chemical companies may pressure pricing and market share.
  • Regulatory changes in key markets could affect product development and sales strategies.
  • Economic downturns may lead to reduced demand for industrial enzymes across various sectors.

What Are the Growth Opportunities for NVZMF?

  • Growth opportunity 1: The global enzymes market is expected to reach $10 billion by 2026, driven by increasing demand in the food and beverage sector. Novozymes can leverage its innovative enzyme solutions to capture a larger market share, particularly in baking and dairy applications, which are projected to grow significantly over the next few years.
  • Growth opportunity 2: The agricultural biotechnology market is anticipated to grow at a CAGR of 10% through 2025, with rising awareness of sustainable farming practices. Novozymes' bioyield and biocontrol solutions for crops position the company to benefit from this trend, enhancing crop productivity and sustainability.
  • Growth opportunity 3: The household care market is evolving towards more sustainable cleaning solutions, with a projected growth rate of 5% annually. Novozymes' enzyme-based cleaning products can capitalize on this trend, offering consumers effective and environmentally friendly alternatives to traditional cleaning agents.
  • Growth opportunity 4: The textile industry is increasingly adopting biotechnological solutions for processing and finishing, with a market expected to grow by 7% annually. Novozymes' textile solutions, such as biopreparation and biopolishing, provide a competitive edge in this sector, aligning with the industry's shift towards sustainability.
  • Growth opportunity 5: The pharmaceutical industry is expanding rapidly, with biocatalysis gaining traction for drug development. Novozymes' solutions, including lipases and proteases, cater to this growing market, providing innovative biocatalytic processes that enhance drug efficacy and production efficiency.

What Opportunities Does NVZMF Have?

  • Growing demand for sustainable solutions in various industries.
  • Expansion into emerging markets with increasing industrialization.
  • Development of new products to meet evolving consumer needs.
  • Strategic partnerships to enhance market reach and capabilities.

What Are NVZMF's Competitive Advantages?

  • Strong brand reputation built over nearly a century in the industry.
  • Extensive research and development capabilities driving innovation.
  • Diverse product portfolio catering to multiple sectors reduces risk.
  • Established global presence enhances market access and distribution.
  • Commitment to sustainability aligns with current market trends.

What Does NVZMF Do?

Founded in 1925 and headquartered in Bagsvaerd, Denmark, Novozymes A/S has established itself as a global leader in the production and sale of industrial enzymes, microorganisms, and probiotics. The company has evolved significantly over the decades, responding to the growing demand for sustainable solutions in various industries. Novozymes operates across multiple sectors, including food and beverage, where it provides solutions for baking, dairy, and beverages, enhancing product quality and efficiency. In the household care industry, Novozymes offers cleaning solutions that improve performance while reducing environmental impact. The agriculture sector benefits from Novozymes' innovations in crop production and animal health, promoting sustainable farming practices. Additionally, the company supplies solutions for textile, pulp and paper, leather, and water management, showcasing its diverse product portfolio. With a strong commitment to research and development, Novozymes continues to push the boundaries of biotechnology, ensuring its competitive edge in the global market. The company's operations span Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America, allowing it to leverage growth opportunities across various regions.

What Products and Services Does NVZMF Offer?

  • Produce industrial enzymes for various applications including food and beverage.
  • Offer household care solutions for laundry, dishwashing, and cleaning.
  • Provide agricultural solutions to enhance crop production and animal health.
  • Develop textile solutions for processing and finishing fabrics.
  • Supply solutions for pulp and paper, leather, and water management.
  • Innovate in pharmaceutical solutions for biocatalysis and human health.

How Does NVZMF Make Money?

  • Generate revenue through the sale of industrial enzymes and microorganisms.
  • Offer customized solutions tailored to specific industry needs.
  • Leverage research and development to create innovative products.
  • Establish long-term partnerships with key players across various sectors.
  • Focus on sustainability to meet growing consumer demand for eco-friendly products.

What Industry Does NVZMF Operate In?

The specialty chemicals industry is characterized by rapid innovation and increasing demand for sustainable solutions. As environmental concerns rise, companies like Novozymes A/S are well-positioned to capitalize on the shift towards eco-friendly products. The global enzymes market is projected to grow at a CAGR of 6.9% from 2021 to 2026, driven by applications in food, agriculture, and household care. Novozymes faces competition from peers such as ACRB, AIQUF, AKZOF, AKZOY, and APD, each vying for market share in this dynamic landscape. The company's extensive product range and commitment to sustainability differentiate it from competitors.

Who Are NVZMF's Key Customers?

  • Food and beverage manufacturers seeking quality enhancement solutions.
  • Household care brands looking for effective cleaning products.
  • Agricultural companies focused on improving crop yields.
  • Textile manufacturers aiming for sustainable processing methods.
  • Pharmaceutical companies requiring biocatalytic processes for drug development.
Model self-rating on this text: 74% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Medium 45/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scoring coverage unknown
  • Price is current
  • Latest filing 73 days ago
  • No analyst coverage
  • Reported in EUR, converted to USD

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 41
2026-08-26 41
2026-08-29 41
2026-09-01 41
2026-09-04 41
2026-09-07 41
2026-09-10 41

What changed?

The score has stayed at 41.

Over the same 18 days the stock moved -4.1%.

2/8 beats

Earnings Track Record

Novozymes A/S has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 18.3% below estimates on average.

Quarterly Financial Performance: Novozymes A/S

Revenue for Novozymes A/S came in at $1.29B during Q2 FY2026. The company recorded net income of $198.4M, with diluted EPS of $0.43. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Basic Materials. Across the four most recent quarters, NVZMF averaged $0.39 in diluted EPS.

NVZMF Valuation & Market Position

With a $30.6B market cap, Novozymes A/S sits in the large-cap segment of the market.

ROE 6%

Key Financial Metrics

Return on equity for Novozymes A/S stands at 5.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.6%, showing how much profit it generates from its asset base. NVZMF trades at a trailing price-to-earnings ratio of 41.02, above the Basic Materials sector average of ~21.40x. Its free cash flow yield is 3.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.67 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.3%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9

Financial Health

Novozymes A/S's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 23.51 places it in the safe zone, indicating low near-term bankruptcy risk.

Company Profile

Novozymes A/S operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Lyngby, DK. The company is led by CEO Ester Baiget. NVZMF has traded publicly since 2010.

NVZMF Financials

Fundamental Snapshot

Revenue Growth (FY)
+8.5%
Net Income Growth (FY)
+91.0%
EPS Growth (FY)
+86.6%
Free Cash Flow Growth (FY)
+13.7%
P/E (TTM)
41.02
Return on Equity (TTM)
+5.5%
Current Ratio
1.7
EV/EBITDA (TTM)
19.2

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Leading position in the industrial enzymes market.
  • Strong commitment to sustainability and innovation.
  • Diverse product offerings across multiple sectors.
  • Robust financial performance with healthy margins.

Bear Case

  • Dependence on raw material prices which can be volatile.
  • Limited market presence in certain emerging regions.
  • Potential regulatory challenges in different markets.
  • High competition from established and emerging players.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $1.29B $198M $0.43
Q1 FY2026 $1.30B $231M $0.50
Q4 FY2025 $1.16B $142M $0.30
Q3 FY2025 $1.23B $160M $0.34

Q2 FY2026 · filed 30 Jun 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis · Converted to USD from EUR at today's rate

NVZMF Latest News

NVZMF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NVZMF.

Price Targets

Wall Street price target analysis for NVZMF.

NVZMF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for NVZMF; grades run from A+ (80-100) to F (below 30).

Leadership: Ester Baiget

CEO

Ester Baiget has a rich background in biotechnology and business management, holding a degree in Chemical Engineering. She has held various leadership roles within Novozymes, focusing on innovation and sustainability. Before becoming CEO, she was responsible for the company's global operations, driving strategic initiatives to enhance growth and efficiency.

Track Record: Under Ester Baiget's leadership, Novozymes has strengthened its market position through innovative product development and strategic partnerships. She has successfully led initiatives that align with sustainability goals, enhancing the company's reputation and market reach.

NVZMF OTC Market Information

The OTC Other tier includes companies that do not meet the requirements for higher tiers like NYSE or NASDAQ. This tier typically has less stringent reporting requirements and may involve lower liquidity and transparency.

  • OTC Tier: OTC Other
Liquidity: Trading volume for NVZMF can be lower than that of stocks on major exchanges, which may lead to wider bid-ask spreads. Investors should be aware of potential trading difficulties, particularly during periods of low volume.
OTC Risk Factors:
  • Lower liquidity compared to stocks listed on major exchanges.
  • Potential for higher volatility due to lower trading volumes.
  • Less stringent reporting requirements may lead to information asymmetry.
  • Increased risk of price manipulation in thinly traded shares.
Due Diligence Checklist:
  • Verify the company's financial health through recent reports.
  • Assess the competitive landscape and market position.
  • Review recent news and developments related to the company.
  • Evaluate the management team's track record and strategy.
  • Consider the company's sustainability practices and initiatives.
Legitimacy Signals:
  • Established history since 1925 with a strong brand reputation.
  • Transparent communication of financial results and business strategies.
  • Active engagement in sustainability and corporate responsibility.
  • Membership in industry associations and compliance with regulations.

Novozymes A/S Basic Materials Stock: Key Questions Answered

Is NVZMF a good stock?

Stock Expert AI does not rate NVZMF buy, sell or hold. Novozymes A/S has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What are the key financial metrics investors watch for NVZMF?

Key financial metrics for Novozymes A/S include its market capitalization of $30.6B, P/E ratio of 41.02, and profit margin of 8.4%.

What are the key factors to evaluate for NVZMF?

Evaluate NVZMF on fundamentals, analyst consensus, and risk factors. P/E: 41.02x vs the S&P 500's ~20-25x. The company's profit margin of 8.4% and gross margin of 53.6% indicate strong operational efficiency. Not financial advice.

How frequently does NVZMF data refresh on this page?

NVZMF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven NVZMF's recent stock price performance?

Novozymes A/S (NVZMF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Leading position in the industrial enzymes market. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider NVZMF overvalued or undervalued right now?

Novozymes A/S (NVZMF) trades at 41.02x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of NVZMF?

Yes, most major brokerages offer fractional shares of Novozymes A/S (NVZMF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track NVZMF's earnings and financial reports?

Novozymes A/S (NVZMF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for NVZMF earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Data is based on the latest available financial reports and market analysis.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover